Antibe Therapeutics Inc. (ATBPF)
USD 0.22
(0.19%)
USD 0.22
(0.19%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 20.54 Million CAD | -19.52% |
| 2022 | 25.52 Million CAD | -8.21% |
| 2021 | 27.81 Million CAD | 31.15% |
| 2020 | 21.2 Million CAD | 34.75% |
| 2019 | 15.73 Million CAD | 56.76% |
| 2018 | 10.03 Million CAD | 9.81% |
| 2017 | 9.14 Million CAD | 74.73% |
| 2016 | 5.23 Million CAD | 18.35% |
| 2015 | 4.42 Million CAD | 65.51% |
| 2014 | 2.67 Million CAD | 162.2% |
| 2013 | 1.01 Million CAD | 8.13% |
| 2012 | 942.13 Thousand CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 5.44 Million CAD | -13.23% |
| 2024 Q3 | 4.59 Million CAD | -15.65% |
| 2024 Q1 | 6.28 Million CAD | 75.32% |
| 2023 Q3 | 4.66 Million CAD | -28.34% |
| 2023 Q4 | 3.58 Million CAD | -23.17% |
| 2023 Q2 | 6.5 Million CAD | 12.25% |
| 2023 Q1 | 5.79 Million CAD | 6.27% |
| 2023 FY | 20.54 Million CAD | -19.52% |
| 2022 Q4 | 5.45 Million CAD | 4.2% |
| 2022 Q2 | 8.38 Million CAD | 13.38% |
| 2022 Q1 | 7.39 Million CAD | 13.03% |
| 2022 FY | 25.52 Million CAD | -8.21% |
| 2022 Q3 | 5.23 Million CAD | -37.61% |
| 2021 Q1 | 5.43 Million CAD | -10.64% |
| 2021 FY | 27.81 Million CAD | 31.15% |
| 2021 Q3 | 7.11 Million CAD | -19.46% |
| 2021 Q4 | 6.54 Million CAD | -7.98% |
| 2021 Q2 | 8.83 Million CAD | 62.64% |
| 2020 Q2 | 5.78 Million CAD | 37.34% |
| 2020 Q3 | 5.12 Million CAD | -11.41% |
| 2020 Q4 | 6.07 Million CAD | 18.57% |
| 2020 FY | 21.2 Million CAD | 34.75% |
| 2020 Q1 | 4.21 Million CAD | -15.47% |
| 2019 Q3 | 4.23 Million CAD | 39.11% |
| 2019 Q4 | 4.98 Million CAD | 17.78% |
| 2019 FY | 15.73 Million CAD | 56.76% |
| 2019 Q1 | 3.47 Million CAD | 27.25% |
| 2019 Q2 | 3.04 Million CAD | -12.57% |
| 2018 Q1 | 2.62 Million CAD | -9.68% |
| 2018 FY | 10.03 Million CAD | 9.81% |
| 2018 Q4 | 2.73 Million CAD | 19.87% |
| 2018 Q3 | 2.28 Million CAD | -4.8% |
| 2018 Q2 | 2.39 Million CAD | -8.83% |
| 2017 Q2 | 1.88 Million CAD | -9.56% |
| 2017 FY | 9.14 Million CAD | 74.73% |
| 2017 Q4 | 2.9 Million CAD | 28.63% |
| 2017 Q3 | 2.26 Million CAD | 19.97% |
| 2017 Q1 | 2.08 Million CAD | -19.19% |
| 2016 Q2 | 757.09 Thousand CAD | 99.05% |
| 2016 FY | 5.23 Million CAD | 18.35% |
| 2016 Q4 | 2.57 Million CAD | 70.28% |
| 2016 Q3 | 1.51 Million CAD | 100.12% |
| 2016 Q1 | 380.35 Thousand CAD | -41.62% |
| 2015 FY | 4.42 Million CAD | 65.51% |
| 2015 Q2 | 1.28 Million CAD | -20.1% |
| 2015 Q1 | 1.6 Million CAD | 81.99% |
| 2015 Q4 | 651.51 Thousand CAD | -26.03% |
| 2015 Q3 | 880.76 Thousand CAD | -31.35% |
| 2014 Q2 | 544.14 Thousand CAD | 84.04% |
| 2014 FY | 2.67 Million CAD | 162.2% |
| 2014 Q4 | 882.34 Thousand CAD | -7.03% |
| 2014 Q3 | 949.04 Thousand CAD | 74.41% |
| 2014 Q1 | 295.66 Thousand CAD | 15.78% |
| 2013 FY | 1.01 Million CAD | 8.13% |
| 2013 Q4 | 255.35 Thousand CAD | -26.7% |
| 2013 Q3 | 348.37 Thousand CAD | 51.56% |
| 2013 Q2 | 229.86 Thousand CAD | 24.14% |
| 2013 Q1 | 185.15 Thousand CAD | 0.0% |
| 2012 FY | 942.13 Thousand CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| IR-Med Inc. | 4.89 Million USD | -319.82% |
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 740.67 Thousand USD | -2673.952% |
| Medical Supply International USA, Inc. | 1.32 Million USD | -1455.93% |
| Polarean Imaging plc | 12.24 Million USD | -67.826% |
| Avitar, Inc. | 3.56 Million USD | -475.597% |
| AVITA Medical, Inc. | 80.77 Million USD | 74.565% |
| Manhattan Scientifics, Inc. | 703 Thousand USD | -2822.617% |
| Össur hf. | 396.18 Million USD | 94.814% |
| Zecotek Photonics Inc. | 3.46 Million USD | -493.567% |
| QHSLab, Inc. | 961.65 Thousand USD | -2036.529% |
| Wellstar International, Inc. | 1.79 Million USD | -1044.818% |
| Össur hf. | 396.18 Million USD | 94.814% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 21.77 Million USD | 5.657% |
| Escalon Medical Corp. | 5.25 Million USD | -291.303% |
| Aurora Spine Corporation | 8.65 Million USD | -137.321% |
| BrainsWay Ltd. | 28.01 Million USD | 26.669% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 9.56 Million USD | -114.819% |
| Hamilton Thorne Ltd. | 33.57 Million USD | 38.801% |
| Vivos Inc. | 2.78 Million USD | -637.179% |
| MicroPort Scientific Corporation | 1.04 Billion USD | 98.04% |
| Kelyniam Global, Inc. | 2.27 Million USD | -803.024% |
| REMSleep Holdings, Inc. | 1.01 Million USD | -1924.43% |
| CYduct Diagnostics, Inc. | 435.5 Thousand USD | -4617.796% |
| Nanomix Corporation | 8.36 Million USD | -145.539% |
| Theraclion SA | 7.43 Million USD | -176.162% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 1.29 Million USD | -1487.081% |
| Positron Corporation | 1 Million USD | -1939.74% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.11 Million USD | -560.548% |
| Lombard Medical, Inc. | 30.29 Million USD | 32.169% |
| ALR Technologies Inc. | 6.33 Million USD | -224.274% |
| Stratec SE | 46.32 Million USD | 55.644% |
| Vycor Medical, Inc. | 1.27 Million USD | -1510.866% |
| Heart Tronics, Inc. | 14.46 Million USD | -42.088% |
| Nu-Med Plus, Inc. | 120.52 Thousand USD | -16946.944% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -9853.541% |
| SANUWAVE Health, Inc. | 14.15 Million USD | -45.191% |
| VMS Rehab Systems, Inc. | 63.63 USD | -32289700.409% |
| Guided Therapeutics, Inc. | 3.49 Million USD | -488.205% |
| Ingen Technologies, Inc. | 1.88 Million USD | -991.583% |
| Odyssey Group International, Inc. | -14.26 Million USD | 244.07% |
| United American Healthcare Corporation | 59 Thousand USD | -34723.729% |
| ECGI Holdings, Inc. | 407.48 Thousand USD | -4942.149% |
| Capital Group Holdings, Inc. | 634.68 Thousand USD | -3137.181% |
| ADM Tronics Unlimited, Inc. | 1.69 Million USD | -1111.749% |
| Urologix, Inc. | 10.09 Million USD | -103.587% |
| Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | -1526.333% |
| Nexeon MedSystems Inc. | 5.94 Million USD | -245.409% |
| SS Innovations International, Inc. | 21.38 Million USD | 3.909% |
| Qualis Innovations, Inc. | 230.24 Thousand USD | -8823.693% |
| Smith & Nephew plc | 3.46 Billion USD | 99.407% |
| NIOX Group Plc | 22.27 Million USD | 7.772% |
| Fuse Medical, Inc. | 10.35 Million USD | -98.512% |
| Broncus Holding Corporation | 38.15 Million USD | 46.146% |
| Brain Scientific Inc. | 9.66 Million USD | -112.631% |
| Pressure BioSciences, Inc. | 10.3 Million USD | -99.419% |
| Health Logic Interactive Inc. | 60.69 Thousand USD | -33749.55% |